219 related articles for article (PubMed ID: 32513697)
1. Myeloid ALX/FPR2 regulates vascularization following tissue injury.
Sansbury BE; Li X; Wong B; Patsalos A; Giannakis N; Zhang MJ; Nagy L; Spite M
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14354-14364. PubMed ID: 32513697
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
Pierdomenico AM; Recchiuti A; Simiele F; Codagnone M; Mari VC; Davì G; Romano M
J Biol Chem; 2015 Feb; 290(6):3592-600. PubMed ID: 25505240
[TBL] [Abstract][Full Text] [Related]
3. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.
Petri MH; Laguna-Fernández A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Bäck M
Cardiovasc Res; 2015 Jan; 105(1):65-74. PubMed ID: 25341894
[TBL] [Abstract][Full Text] [Related]
4. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.
Waechter V; Schmid M; Herova M; Weber A; Günther V; Marti-Jaun J; Wüst S; Rösinger M; Gemperle C; Hersberger M
J Immunol; 2012 Feb; 188(4):1856-67. PubMed ID: 22246625
[TBL] [Abstract][Full Text] [Related]
7. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
[TBL] [Abstract][Full Text] [Related]
8. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the formyl peptide receptor 2 gene.
Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
[TBL] [Abstract][Full Text] [Related]
11. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
Nunes VS; Abrahão O; Rogério AP; Serhan CN
J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
[TBL] [Abstract][Full Text] [Related]
12. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.
Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA
Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
Schmitz Nunes V; Rogério AP; Abrahão O
J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
[TBL] [Abstract][Full Text] [Related]
14. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
Wang CS; Wee Y; Yang CH; Melvin JE; Baker OJ
Sci Rep; 2016 Apr; 6():24244. PubMed ID: 27064029
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
16. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.
Nelson JW; Leigh NJ; Mellas RE; McCall AD; Aguirre A; Baker OJ
Am J Physiol Cell Physiol; 2014 Jan; 306(2):C178-85. PubMed ID: 24259417
[TBL] [Abstract][Full Text] [Related]
17. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
[TBL] [Abstract][Full Text] [Related]
18. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity.
Simiele F; Recchiuti A; Mattoscio D; De Luca A; Cianci E; Franchi S; Gatta V; Parolari A; Werba JP; Camera M; Favaloro B; Romano M
FASEB J; 2012 Mar; 26(3):1323-33. PubMed ID: 22131270
[TBL] [Abstract][Full Text] [Related]
20. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A
Pierdomenico AM; Patruno S; Codagnone M; Simiele F; Mari VC; Plebani R; Recchiuti A; Romano M
Sci Rep; 2017 Oct; 7(1):13519. PubMed ID: 29044225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
